Jill Couch, DO
Hospitalist · Norton, VANPI 1972561702
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,337, 2.3 times the $580 reported in 2019. Among hospitalist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $25.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$397
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$307
- Novo Nordisk$265
- AbbVie$250
- Alkermes, Inc.$247
- Astellas Pharma US Inc$237
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,184100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $397 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $307 |
| Novo Nordisk | 13 | $265 |
| AbbVie(2 entities) | 20 | $250 |
| Alkermes, Inc. | 2 | $247 |
| Astellas Pharma US Inc | 13 | $237 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $214 |
| Otsuka America Pharmaceutical, Inc. | 5 | $194 |
| Vanda Pharmaceuticals Inc. | 2 | $161 |
| 3b Medical, Inc. | 1 | $149 |
| Axsome Therapeutics, Inc. | 3 | $141 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| GSK | 6 | $100 |
| Abbott | 4 | $69 |
| Lilly USA, LLC | 3 | $58 |
| Novartis | 4 | $54 |
| Johnson & Johnson | 2 | $43 |
| Boehringer Ingelheim | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$500
- ARISTADA$490
- LUNA$149
- Tresiba$125
- BREZTRI$125
- Fanapt$125
- COBENFY$125
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- AIRSUPRA$125
- CAPLYTA$125
- ARISTADA INITIO$122
- Auvelity$111
How this compares
$3,184 in reported general payments places this provider in the 95th percentile of 539 hospitalist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 196 | $228,333 |
| OzempicSemaglutide | 187 | $216,294 |
| MounjaroTirzepatide | 124 | $141,234 |
| JardianceEmpagliflozin | 73 | $91,156 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 70 | $87,797 |
| JanuviaSitagliptin Phosphate | 62 | $84,471 |
| TrulicityDulaglutide | 77 | $83,843 |
| EntrestoSacubitril/Valsartan | 42 | $42,494 |
| XareltoRivaroxaban | 25 | $37,660 |
| VraylarCariprazine Hcl | 24 | $36,432 |
| Tresiba Flextouch U-100Insulin Degludec | 37 | $31,281 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $30,296 |
| LinzessLinaclotide | 36 | $27,360 |
| Spiriva HandihalerTiotropium Bromide | 38 | $24,480 |
| FarxigaDapagliflozin Propanediol | 29 | $21,162 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $12 | $228,333196 claims |
| Lilly USA, LLCMounjaro, Trulicity | $58 | $225,077201 claims |
| Novo NordiskOzempic, Tresiba | $265 | $221,367203 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat, Spiriva Respimat, Stiolto Respimat | $35 | $150,067148 claims |
| GSKTrelegy Ellipta | $100 | $87,79770 claims |
| AbbVieVraylar, Linzess, Savella | $250 | $72,27777 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta | $397 | $70,593110 claims |
| NovartisEntresto | $54 | $42,49442 claims |
| Johnson & JohnsonXarelto | $43 | $37,66025 claims |
| Astellas Pharma US IncMyrbetriq | $237 | $18,34023 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 539 hospitalist providers in Virginia.
Other hospitalist in Norton
- William AllsNorton$1K
- Yuri MaricichCharlottesville$212K
- Dennis NguyenSpringfield$8K
- Muhammad AfridiWinchester$7K
- Lana WahidRoanoke$6K
- Emily KinseyRichmond$5K
- Mohammed AmerNewport News$5K
- John MelsonCharlottesville$2K
- Lisa HuangChesapeake$2K
- Roya QaemiFredericksburg$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.